Ikach blocker
Ikach blocker has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 25, 2022: “IKACh is constitutively active via PKC epsilon in aging mediated atrial fibrillation”.
1 paper studies it1 findingUpdated
See all 1 papers on ikach blocker
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: National Heart, Lung, and Blood Institute and 3 more
- Animals1
What is ikach blocker linked with?
1Studies link ikach blocker with 1 measure, most often atrial fibrillation (1 study).
Atrial fibrillation
downin mice1
1 study
Atrial fibrillation
downin mice1
Ikach blocker lowers the risk of atrial fibrillation in mice.
“blocking this abnormal current in the old heart reduces AF inducibility.”
Animalsheart
IKACh is constitutively active via PKC epsilon in aging mediated atrial fibrillation
iScience
Latest
iScience
IKACh is constitutively active via PKC epsilon in aging mediated atrial fibrillation
Experiments in miceMechanisms